Dietary lipid type, rather than total number of calories, alters outcomes of enteric infection in mice

Journal of Infectious Diseases

Volumn 213, Issue 11, 2016, Pages 1846-1856

  DeCoffe, Daniella ^a   Quin, Candice ^a   Gill, Sandeep K ^a   Tasnim, Nishat ^a   Brown, Kirsty ^a   Godovannyi, Artem ^a   Dai, Chuanbin ^a   Abulizi, Nijiati ^a   Chan, Yee Kwan ^a   Ghosh, Sanjoy ^a   Gibson, Deanna L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Citrobacter rodentium infection; colitis; Corn oil; Fish oil; high fat diets; Inflammation; Intestinal alkaline phosphatase; Milk fat; nutrition; Olive oil

Indexed keywords

ALKALINE PHOSPHATASE; CORN OIL; FISH OIL; LIPOPOLYSACCHARIDE; MILK FAT; MONOUNSATURATED FATTY ACID; N 6 POLYUNSATURATED FATTY ACID; OLIVE OIL; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; SATURATED FATTY ACID; UNCLASSIFIED DRUG; FAT INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; CALORIC INTAKE; CITROBACTER RODENTIUM; CONTROLLED STUDY; DISEASE PREDISPOSITION; ENZYME ACTIVITY; FEMALE; INTESTINE INFECTION; LIMIT OF QUANTITATION; LIPID DIET; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; C57BL MOUSE; CACO-2 CELL LINE; COLON; DIET THERAPY; ENTEROBACTERIACEAE INFECTIONS; FAT INTAKE; HUMAN; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MILK; PHOSPHORYLATION; THERAPEUTIC USE; TREATMENT OUTCOME;

ANIMALS; CACO-2 CELLS; CITROBACTER RODENTIUM; COLON; CORN OIL; DIET, HIGH-FAT; DIETARY FATS; DISEASE SUSCEPTIBILITY; ENERGY INTAKE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; FISH OILS; HUMANS; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED C57BL; MILK; OLIVE OIL; PHOSPHORYLATION; TREATMENT OUTCOME;

EID: 84978698199     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw084     Document Type: Article

References (46)

1. Simopoulos AP. Essential fatty acids in health and chronic disease. Am J Clin Nutr 1999; 70:560S-9.
2. Brown K, DeCoffe D, Molcan E, Gibson DL. Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease. Nutrients 2012; 4:1095-119.
3. Chan YK, Estaki M, Gibson DL. Clinical consequences of diet-induced dysbiosis. Ann Nutr Meta 2013; 63:28-40.
4. Huang S, Rutkowsky JM, Snodgrass RG, et al. Saturated fatty acids activate TLRmediated proinflammatory signaling pathways. J Lipid Res 2012; 53:2002-13.
5. Devkota S, Wang Y, Musch MW, et al. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/-mice. Nature 2012; 487:104-8.
6. Bagga D,Wang L, Farias-Eisner R, Glaspy JA, Reddy ST. Differential effects of prostaglandin derived from omega-6 and omega-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci U S A 2003; 100:1751-6.
7. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83:1505S-19.
8. Gibson D, Gill S, Brown K, et al. Maternal exposure to fish oil primes offspring to harbor intestinal pathobionts associated with altered immune cell balance. Gut Microbes 2015; 6:24-32.
9. McFarland CT, Fan YY, Chapkin RS, Weeks BR, McMurray DN. Dietary polyunsaturated fatty acids modulate resistance to Mycobacterium tuberculosis in guinea pigs. J Nutr 2008; 138:2123-8.
10. Woodworth HL, McCaskey SJ, Duriancik DM, et al. Dietary fish oil alters T lymphocyte cell populations and exacerbates disease in a mouse model of inflammatory colitis. Cancer Res 2010; 70:7960-9.
11. Ghosh S, DeCoffe D, Brown K, et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One 2013; 8:e55468.
12. Micha R, Khatibzadeh S, Shi P, et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ 2014; 348:g2272.
13. Ochoa TJ, Contreras CA. Enteropathogenic Escherichia coli infection in children. Curr Opin Infect Dis 2011; 24:478-83.
14. Deng W, Li Y, Vallance BA, Finlay BB. Locus of enterocyte effacement from Citrobacter rodentium: sequence analysis and evidence for horizontal transfer among attaching and effacing pathogens. Infect Immun 2001; 69:6323-35.
15. Higgins LM, Frankel G, Douce G, Dougan G, MacDonald TT. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect Immun 1999; 67:3031-9.
16. Fenton JI, Hord NG, Ghosh S, Gurzell EA. Immunomodulation by dietary long chain omega-3 fatty acids and the potential for adverse health outcomes. Prostaglandins Leukot Essent Fatty Acids 2013; 89:379-90.
17. Gibson DL, Ma C, Rosenberger CM, et al. Toll-like receptor 2 plays a critical role in maintaining mucosal integrity during Citrobacter rodentium-induced colitis. Cell Microbiol 2008; 10:388-403.
18. Ghosh S, Dai C, Brown K, et al. Colonic microbiota alters host susceptibility to infectious colitis by modulating inflammation, redox status, and ion transporter gene expression. Am J Phys Gastrointest Liver Physiol 2011; 301:G39-49.
19. Ghosh S, DeCoffe D, Brown K, et al. Fish oil attenuates omega-6 polyunsaturated fatty acid-induced dysbiosis and infectious colitis but impairs LPS dephosphorylation activity causing sepsis. PLoS One 2013; 8:e55468.
20. Baker J, Brown K, Rajendiran E, et al. Medicinal lavender modulates the enteric microbiota to protect against Citrobacter rodentium-induced colitis. Am J Physiol Gastrointest Liver Physiol 2012; 303:G825-36.
21. Baykov AA, Evtushenko OA, Avaeva SM. A malachite green procedure for orthophosphate determination and its use in alkaline phosphatase-based enzyme immunoassay. Anal Biochem 1988; 171:266-70.
22. Leverton LQ, Kaper JB. Temporal expression of enteropathogenic Escherichia coli virulence genes in an in vitro model of infection. Infect Immun 2005; 73:1034-43.
23. Brown K, Godovannyi A, Ma C, et al. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice. ISME J 2015; 10:321-32.
24. Lebeis SL, Sherman MA, Kalman D. Protective and destructive innate immune responses to enteropathogenic Escherichia coli and related A/E pathogens. Future Microbiol 2008; 3:315-28.
25. Gibson DL, Ma C, Bergstrom KS, Huang JT, Man C, Vallance BA. MyD88 signalling plays a critical role in host defence by controlling pathogen burden and promoting epithelial cell homeostasis during Citrobacter rodentium-induced colitis. Cell Microbiol 2008; 10:618-31.
26. Gibson DL, Montero M, Ropeleski MJ, et al. Interleukin-11 Reduces TLR4-Induced Colitis in TLR2-Deficient Mice and Restores Intestinal STAT3 Signaling. Gastroenterology 2010; 139:1277-88.
27. Kim MH, Kang SG, Park JH, Yanagisawa M, Kim CH. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology 2013; 145:396-406 e1-10.
28. Puertollano E, Kolida S, Yaqoob P. Biological significance of short-chain fatty acid metabolism by the intestinal microbiome. Curr Opin Clin Nutr Metab Care 2014; 17:139-44.
29. Al-Lahham SH, Peppelenbosch MP, Roelofsen H, Vonk RJ, Venema K. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. Biochim Biophys Acta 2010; 1801:1175-83.
30. Domar U, Nilsson B, Baranov V, Gerdes U, Stigbrand T. Expression of intestinal alkaline phosphatase in human organs. Histochemistry 1992; 98:359-64.
31. Goldberg RF, Austen WG Jr., Zhang X, et al. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc Natl Acad Sci U S A 2008; 105:3551-6.
32. Martinez-Moya P, Ortega-Gonzalez M, Gonzalez R, et al. Exogenous alkaline phosphatase treatment complements endogenous enzyme protection in colonic inflammation and reduces bacterial translocation in rats. Pharmacol Res 2012; 66:144-53.
33. The Food Guide Pyramid. http://www.cnpp.usda.gov/sites/default/files/archived-projects/FGPPamphlet.pdf. Accessed 16 March 2016.
34. Ghosh S, Molcan E, DeCoffe D, Dai C, Gibson DL. Diets rich in n-6 PUFA induce intestinal microbial dysbiosis in aged mice. Br J Nutr 2013; 110:515-23.
35. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science 2013; 341:569-73.
36. Turnquist HR, Zhao Z, Rosborough BR, et al. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol 2011; 187:4598-610.
37. Shen S, Ding Y, Tadokoro CE, et al. Control of homeostatic proliferation by regulatory T cells. J Clin Invest 2005; 115:3517-26.
38. Loonen LM, Stolte EH, Jaklofsky MT, et al. REG3gamma-deficient mice have altered mucus distribution and increased mucosal inflammatory responses to the microbiota and enteric pathogens in the ileum. Mucosal Immunol 2014; 7:939-47.
39. de Lorgeril M, Salen P. New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med 2012; 10:50.
40. Camuesco D, Galvez J, Nieto A, et al. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr 2005; 135:687-94.
41. Sanchez-Fidalgo S, Villegas I, Cardeno A, et al. Extra-virgin olive oil-enriched diet modulates DSS-colitis-Associated colon carcinogenesis in mice. Clin Nutr 2010; 29:663-73.
42. Cleary J, Lai LC, Shaw RK, et al. Enteropathogenic Escherichia coli (EPEC) adhesion to intestinal epithelial cells: role of bundle-forming pili (BFP), EspA filaments and intimin. Microbiology 2004; 150:527-38.
43. Beumer C, Wulferink M, Raaben W, Fiechter D, Brands R, Seinen W. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets. J Pharmacol Exp Ther 2003; 307:737-44.
44. Das UN. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-Arrhythmic, antihypertensive, anti-Atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008; 7:37.
45. Rose DP, Connolly JM. Omega-3 fatty acids as cancer chemopreventive agents. Pharmacol Ther 1999; 83:217-44.
46. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000; 71:343S-8.